SEC Form D filing

TwoStep Therapeutics, Inc., 2026-01-20

An SEC Form D private-offering notice from San Carlos, CA, a $62,209,510 filer-stated offering target in Biotech. Filed 2026-01-20. The source filing is one click away. For companies that filed this week, open the live feed.

What this filing says

TwoStep Therapeutics, Inc. site↗ Verified via SEC Form D

Biotechnology company developing targeted peptide conjugate and radiopharmaceutical therapies for solid tumors, co-founded with Stanford researchers including Carolyn Bertozzi.

Filed 2026-01-20Filed to raise $62,209,510First money in 2026-01-09Raised so far $21,109,518HQ (as filed) San Carlos, CASector Biotech web-verified against the company’s own siteStage (inferred) GrowthCall status Call-ready
Source linked the Form D on EDGAR↗Website verified twosteptx.com↗Named in the filing 4 executives & directors

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.

Other Form D filings from the same week

each with its own page and its own EDGAR source